Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (431-440 of 962) with videos related to

Pageof 97
Sort By:
International Journal of Cardiology|December 16, 2014
Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 yearsEtienne Puymirat, François Schiele, Philippe Gabriel Steg, et al.
American Heart Journal|December 3, 2014
Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placementLaurent Feldman, Florence Tubach, Jean-Michel Juliard, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Journal of the American Heart Association|October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) TrialClaes Held, Harvey D White, Ralph A H Stewart, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
Circulation. Cardiovascular Interventions|April 8, 2020
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI TrialNatalia C Berry, Laura Mauri, Philippe Gabriel Steg, et al.
Circulation|April 1, 2020
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical TrialGregory G Schwartz, Philippe Gabriel Steg, Michael Szarek, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
The New England Journal of Medicine|November 13, 2018
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaDeepak L Bhatt, P Gabriel Steg, Michael Miller, et al.
Pageof 97

Showing results (431-440 of 962) with videos related to

Sort By:
Pageof 97
International Journal of Cardiology|December 16, 2014
Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 yearsEtienne Puymirat, François Schiele, Philippe Gabriel Steg, et al.
American Heart Journal|December 3, 2014
Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placementLaurent Feldman, Florence Tubach, Jean-Michel Juliard, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Journal of the American Heart Association|October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) TrialClaes Held, Harvey D White, Ralph A H Stewart, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
Circulation. Cardiovascular Interventions|April 8, 2020
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI TrialNatalia C Berry, Laura Mauri, Philippe Gabriel Steg, et al.
Circulation|April 1, 2020
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical TrialGregory G Schwartz, Philippe Gabriel Steg, Michael Szarek, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
The New England Journal of Medicine|November 13, 2018
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaDeepak L Bhatt, P Gabriel Steg, Michael Miller, et al.
Pageof 97